The authors wish to make the following corrections to this paper [1]:
- 1.
- Addition of an Author
- Dr. Georgia Mavria was not included as an author in the original publication, the correct authorship is as below:
Anke Brüning-Richardson 1,*, Gary C. Shaw 1, Daniel Tams 1, Tim Brend 1, Hitesh Sanganee 2, Simon T. Barry 3, Gregory Hamm 4, Richard J. A. Goodwin 4, John G. Swales 4, Henry King 1, Lynette Steele 1, Ruth Morton 1, Anastasia Widyadari 1, Thomas A. Ward 1, Filomena Esteves 1, Marjorie Boissinot 1, Georgia Mavria 1, Alastair Droop 5, Sean E. Lawler 6 and Susan C. Short 1,*
- The author contribution should also be updated to include GM as below:
Conceptualization, S.C.S. and A.B.-R.; methodology, A.B.-R., G.C.S., D.T., T.B., H.S., S.T.B., G.H., R.J.A.G., J.G.S., H.K., L.S., R.M., A.W., T.A.W., F.E., M.B., A.D., G.M.; software, A.D.; validation, S.C.S., S.E.L.; formal analysis, S.C.S., G.C.S., A.B.-R.; investigation, A.B.-R., G.C.S., D.T., T.B., H.S., S.T.B., G.H., R.J.A.G., J.G.S., H.K., L.S., R.M., A.W., T.A.W., F.E., M.B., A.D.; resources, H.S., S.T.B., G.H., R.J.A.G.; data curation, S.C.S., A.D.; writing—original draft preparation, A.B.-R., S.C.S., S.E.L.; writing—review and editing, S.C.S., S.E.L.; visualization, A.B.-R., S.C.S.; supervision, S.C.S.; project administration, S.C.S.; funding acquisition, S.C.S., A.B.-R. All authors have read and agreed to the published version of the manuscript.
- 2.
- Email Correction
The correct email address of Susan C. Short is s.c.short@leeds.ac.uk
- 3.
- Text Correction
We have also been alerted to an error in affiliation in the text of the paper: In Section 2.1 Cell lines, sentence 2 and 3: In addition, patient-derived cell lines GBM1 and GBM4 [15] were included in this study. Neural progenitor cells (NP1) and normal human astrocytes (NHA) were obtained from Dr Heiko Wurdak (Leeds Institute of Cancer and Pathology). It should be replaced with the following: The patient-derived tumour models GBM1, GBM4, and the adult human brain progenitor line NP1 were a kind gift from H. Wurdak (Stem Cell and Brain Tumour Group, University of Leeds, Leeds, UK) and were used as previously described in [17,18].
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.
Reference
- Brüning-Richardson, A.; Shaw, G.C.; Tams, D.; Brend, T.; Sanganee, H.; Barry, S.T.; Hamm, G.; Goodwin, R.J.A.; Swales, J.G.; King, H.; et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).